| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6126070 | Transplant Immunology | 2013 | 6 Pages |
Abstract
A single dose of rituximab treatment added to standard immunosuppressive therapy in renal transplant patients did not influence the production of IL-17 or other monocyte- or T-cell derived cytokines after ex-vivo stimulation.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sanne P. Smeekens, Martijn W.F. van den Hoogen, Elena G. Kamburova, Frank L. van de Veerdonk, Irma Joosten, Hans J.M.P. Koenen, Mihai G. Netea, Luuk B. Hilbrands, Leo A.B. Joosten,